ID: ALA4461154

Max Phase: Preclinical

Molecular Formula: C19H28N2O2

Molecular Weight: 316.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC1CCCCN1CCCOc1ccc2c(c1)C(=O)N(C)CC2

Standard InChI:  InChI=1S/C19H28N2O2/c1-15-6-3-4-10-21(15)11-5-13-23-17-8-7-16-9-12-20(2)19(22)18(16)14-17/h7-8,14-15H,3-6,9-13H2,1-2H3

Standard InChI Key:  NQIHRGRHGKXFDW-UHFFFAOYSA-N

Associated Targets(non-human)

Histamine H1 receptor 2054 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.45Molecular Weight (Monoisotopic): 316.2151AlogP: 2.96#Rotatable Bonds: 5
Polar Surface Area: 32.78Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.46CX LogP: 2.50CX LogD: 0.45
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: -0.68

References

1. Dou F, Cao X, Jing P, Wu C, Zhang Y, Chen Y, Zhang G..  (2019)  Synthesis and evaluation of histamine H3 receptor ligand based on lactam scaffold as agents for treating neuropathic pain.,  29  (12): [PMID:30981577] [10.1016/j.bmcl.2019.04.015]

Source